{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:22:24Z","timestamp":1792416144283,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T00:00:00Z","timestamp":1460764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00774-016-0756-9","type":"journal-article","created":{"date-parts":[[2016,4,16]],"date-time":"2016-04-16T06:38:26Z","timestamp":1460788706000},"page":"298-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Reports of 17 Chinese patients with tumor-induced osteomalacia"],"prefix":"10.1007","volume":"35","author":[{"given":"Wei-Jia","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Zhen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,16]]},"reference":[{"key":"756_CR1","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader A, Illig R, Uehlinger E, Stalder G (1959) Rickets following bone tumor. Helv Paediatr Acta 14:554\u2013565","journal-title":"Helv Paediatr Acta"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27:1967\u20131975","journal-title":"J Bone Miner Res"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53\u2013R77","journal-title":"Endocr Relat Cancer"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V, Rangarajan V, Chandra P, Shah H, Malhotra G, Jagtap VS, Budyal S, Lila AR, Bandgar T, Shah NS (2014) Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol (Oxf) 81:31\u201337","journal-title":"Clin Endocrinol (Oxf)"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1002\/jbmr.1881","volume":"28","author":"WH Chong","year":"2013","unstructured":"Chong WH, Andreopoulou P, Chen CC, Reynolds J, Guthrie L, Kelly M, Gafni RI, Bhattacharyya N, Boyce AM, El-Maouche D, Crespo DO, Sherry R, Chang R, Wodajo FM, Kletter GB, Dwyer A, Collins MT (2013) Tumor localization and biochemical response to cure in tumor-induced osteomalacia. J Bone Miner Res 28:1386\u20131398","journal-title":"J Bone Miner Res"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1056\/NEJM199406093302310","volume":"330","author":"MJ Econs","year":"1994","unstructured":"Econs MJ, Drezner MK (1994) Tumor-induced osteomalacia\u2014unveiling a new hormone. N Engl J Med 330:1679\u20131681","journal-title":"N Engl J Med"},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294:1260\u20131267","journal-title":"JAMA"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S8756-3282(99)00170-2","volume":"25","author":"S Fukumoto","year":"1999","unstructured":"Fukumoto S, Takeuchi Y, Nagano A, Fujita T (1999) Diagnostic utility of magnetic resonance imaging skeletal survey in a patient with oncogenic osteomalacia. Bone 25:375\u2013377","journal-title":"Bone"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2005.01.001","volume":"36","author":"JL Dupond","year":"2005","unstructured":"Dupond JL, Mahammedi H, Prie D, Collin F, Gil H, Blagosklonov O, Ricbourg B, Meaux-Ruault N, Kantelip B (2005) Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET\/CT scan for the diagnosis and follow-up in one case. Bone 36:375\u2013378","journal-title":"Bone"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4158\/EP.12.1.35","volume":"12","author":"SF Hodgson","year":"2006","unstructured":"Hodgson SF, Clarke BL, Tebben PJ, Mullan BP, Cooney WP 3rd, Shives TC (2006) Oncogenic osteomalacia: localization of underlying peripheral mesenchymal tumors with use of Tc 99m sestamibi scintigraphy. Endocr Pract 12:35\u201342","journal-title":"Endocr Pract"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM, Streeten EA, Civelek AC, McCarthy EF, Uribe L, Marx SJ, Onobrakpeya O, Raisz LG, Watts NB, Sharon M, Levine MA (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359:761\u2013763","journal-title":"Lancet"},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0140-6736(75)92736-1","volume":"2","author":"RJ Walton","year":"1975","unstructured":"Walton RJ, Bijvoet OL (1975) Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309\u2013310","journal-title":"Lancet"},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1097\/MNM.0b013e328358d9c0","volume":"33","author":"ZL Qiu","year":"2012","unstructured":"Qiu ZL, Xue YL, Song HJ, Luo QY (2012) Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT\/CT and 18F-FDG-PET\/CT for the detection of bone metastases from differentiated thyroid cancer. Nucl Med Commun 33:1232\u20131242","journal-title":"Nucl Med Commun"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"KE White","year":"2001","unstructured":"White KE, Carn G, Lorenz-Depiereux B, Benet-Pages A, Strom TM, Econs MJ (2001) Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int 60:2079\u20132086","journal-title":"Kidney Int"},{"key":"756_CR16","doi-asserted-by":"publisher","first-page":"6500","DOI":"10.1073\/pnas.101545198","volume":"98","author":"T Shimada","year":"2001","unstructured":"Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci U S A 98:6500\u20136505","journal-title":"Proc Natl Acad Sci U S A"},{"key":"756_CR17","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429\u2013435","journal-title":"J Bone Miner Res"},{"key":"756_CR18","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00424-002-0839-4","volume":"444","author":"HS Tenenhouse","year":"2002","unstructured":"Tenenhouse HS, Sabbagh Y (2002) Novel phosphate-regulating genes in the pathogenesis of renal phosphate wasting disorders. Pflugers Arch 444:317\u2013326","journal-title":"Pflugers Arch"},{"key":"756_CR19","doi-asserted-by":"publisher","first-page":"4088","DOI":"10.1210\/jc.2002-021919","volume":"88","author":"AE Nelson","year":"2003","unstructured":"Nelson AE, Bligh RC, Mirams M, Gill A, Au A, Clarkson A, Juppner H, Ruff S, Stalley P, Scolyer RA, Robinson BG, Mason RS, Bligh PC (2003) Clinical case seminar: fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 88:4088\u20134094","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"177","DOI":"10.4158\/EP10151.OR","volume":"17","author":"VS Jagtap","year":"2011","unstructured":"Jagtap VS, Sarathi V, Lila AR, Malhotra G, Sankhe SS, Bandgar T, Menon P, Shah NS (2011) Tumor-induced osteomalacia: a single center experience. Endocr Pract 17:177\u2013184","journal-title":"Endocr Pract"},{"key":"756_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/01.rlu.0000257180.03964.51","volume":"32","author":"MC Roarke","year":"2007","unstructured":"Roarke MC, Nguyen BD (2007) PET\/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 32:300\u2013301","journal-title":"Clin Nucl Med"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1097\/RLU.0b013e3181f49e69","volume":"35","author":"G Malhotra","year":"2010","unstructured":"Malhotra G, Agrawal A, Jambhekar NA, Sarathi V, Jagtap V, Agarwal MG, Kulkarni M, Asopa RV, Shah NS (2010) Interesting image. The search for primary tumor in a patient with oncogenic osteomalacia: F-18 FDG PET resolves the conundrum. Clin Nucl Med 35:896\u2013898","journal-title":"Clin Nucl Med"},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.1259\/bjr\/58168443","volume":"81","author":"SC Chua","year":"2008","unstructured":"Chua SC, O\u2019Connor SR, Wong WL, Ganatra RH (2008) Case report: solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET\/CT. A case report with a review of the radiological literature. Br J Radiol 81:e110\u2013e114","journal-title":"Br J Radiol"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh RJ, Hofman MS, Duncan E, Sim Ie W, Darnell D, Clarkson A, Wong T, Walsh JP, Gill AJ, Ebeling PR, Hicks RJ (2013) Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET\/CT. J Clin Endocrinol Metab 98:687\u2013694","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, Schuuze N, Schulz G, Kenn W, Richtmann H, Palitzsch KD, Jakob F (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883\u20131888","journal-title":"N Engl J Med"},{"key":"756_CR26","first-page":"502","volume":"47","author":"R Cescato","year":"2006","unstructured":"Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC (2006) Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists. J Nucl Med 47:502\u2013511","journal-title":"J Nucl Med"},{"key":"756_CR27","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/jbmr.316","volume":"26","author":"P Andreopoulou","year":"2011","unstructured":"Andreopoulou P, Dumitrescu CE, Kelly MH, Brillante BA, Cutler Peck CM, Wodajo FM, Chang R, Collins MT (2011) Selective venous catheterization for the localization of phosphaturic mesenchymal tumors. J Bone Miner Res 26:1295\u20131302","journal-title":"J Bone Miner Res"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bone.2014.04.016","volume":"64","author":"S Breer","year":"2014","unstructured":"Breer S, Brunkhorst T, Beil FT, Peldschus K, Heiland M, Klutmann S, Barvencik F, Zustin J, Gratz KF, Amling M (2014) 68Ga DOTA-TATE PET\/CT allows tumor localization in patients with tumor-induced osteomalacia but negative 111In-octreotide SPECT\/CT. Bone 64:222\u2013227","journal-title":"Bone"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1007\/s00259-006-0317-x","volume":"34","author":"P Antunes","year":"2007","unstructured":"Antunes P, Ginj M, Zhang H, Waser B, Baum RP, Reubi JC, Maecke H (2007) Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? Eur J Nucl Med Mol Imaging 34:982\u2013993","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/RLU.0b013e318279eb13","volume":"38","author":"N Naswa","year":"2013","unstructured":"Naswa N, Sharma P, Kumar R, Malhotra A, Bal C (2013) Successful localization of residual culprit tumor in a case of tumor-induced osteomalacia using 68Ga-DOTANOC PET\/CT. Clin Nucl Med 38:639\u2013640","journal-title":"Clin Nucl Med"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","volume":"35","author":"C Falck von","year":"2008","unstructured":"von Falck C, Rodt T, Rosenthal H, Langer F, Goesling T, Knapp WH, Galanski M (2008) 68Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia. Eur J Nucl Med Mol Imaging 35:1034","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1359\/jbmr.1997.12.9.1502","volume":"12","author":"E Shane","year":"1997","unstructured":"Shane E, Parisien M, Henderson JE, Dempster DW, Feldman F, Hardy MA, Tohme JF, Karaplis AC, Clemens TL (1997) Tumor-induced osteomalacia: clinical and basic studies. J Bone Miner Res 12:1502\u20131511","journal-title":"J Bone Miner Res"},{"key":"756_CR33","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1172\/JCI200319687","volume":"112","author":"LD Quarles","year":"2003","unstructured":"Quarles LD (2003) Evidence for a bone\u2013kidney axis regulating phosphate homeostasis. J Clin Invest 112:642\u2013646","journal-title":"J Clin Invest"},{"key":"756_CR34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1210\/jc.2004-0357","volume":"90","author":"TO Carpenter","year":"2005","unstructured":"Carpenter TO, Ellis BK, Insogna KL, Philbrick WM, Sterpka J, Shimkets R (2005) Fibroblast growth factor 7: an inhibitor of phosphate transport derived from oncogenic osteomalacia-causing tumors. J Clin Endocrinol Metab 90:1012\u20131020","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR35","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.4158\/EP.14.9.1108","volume":"14","author":"MA Habra","year":"2008","unstructured":"Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA Jr, Gagel RF, Hoff AO (2008) Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract 14:1108\u20131114","journal-title":"Endocr Pract"},{"key":"756_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMc070347","volume":"357","author":"E Hesse","year":"2007","unstructured":"Hesse E, Rosenthal H, Bastian L (2007) Radiofrequency ablation of a tumor causing oncogenic osteomalacia. N Engl J Med 357:422\u2013424","journal-title":"N Engl J Med"},{"key":"756_CR37","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1210\/jc.2013-4515","volume":"99","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Shetty NS, Kulkarni S, Rathod K, Popat B, Kakade H, Bukan A, Khare S, Budyal S, Jagtap VS, Lila AR, Bandgar T, Shah NS (2014) Radiofrequency ablation, an effective modality of treatment in tumor-induced osteomalacia: a case series of three patients. J Clin Endocrinol Metab 99:3049\u20133054","journal-title":"J Clin Endocrinol Metab"},{"key":"756_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F et al (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1\u201330","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-016-0756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-016-0756-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-016-0756-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-016-0756-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:16:59Z","timestamp":1559110619000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-016-0756-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,16]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s00774-016-0756-9","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,16]]}}}